Med tech featured in Italian R&D (Research and Development) programme:
This article was originally published in Clinica
Executive Summary
Extracorporeal bioartifical liver systems are among the areas of research to benefit from the latest allocation of special funding by Italy's ministry of universities and scientific & technological research. The 18-month project by Cavezzo, Modena-based company Rand has a budget of Lit2.55 billion ($1.1 million). The latest funding awards, totalling Lit64.8 billion, also support research into the control, cure and prevention of hospital-acquired infection. This two-year project by Bologna-based Dianoema has a budget of Lit1.8 billion.
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.